4.610USD+4.610盤後交易 07/28, 20:00 (美東)
關鍵數據
4.810今開
4.810最高
101.05K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
0.07%換手率
4.750昨收
4.520最低
370.39K成交額
虧損本益比靜
-30.76市淨率
0.00%股息率 TTM
-74.88%ROA
7.12052週最高
0.58量比
-61.84M淨利潤
153.88M總股本
-1.5635每股盈餘TTM
1.88Beta
-1746.27%ROE
3.22052週最低
6.11%振幅
82.00%毛利率
712.48M總市值
2.56回報/風險
4.60%風險率
操作建議
AVITA Medical Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在生物技術與醫療研究行業排名72/386位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為7.00。中期看,股價處於上升通道。近一個月,市場表現較強,基本面評分較高,但較強的走勢沒有得到技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。
壓力支撐

由於公司未披露,未能獲取相關數據
AVITA Medical Inc新聞
即將為您帶來更多新聞,敬請期待。 。 。
收益預測
Ionis Pharmaceuticals Inc
IONS
26
技術指標
財務指標
每股收益

由於公司未披露,未能獲取相關數據
營業總收入

由於公司未披露,未能獲取相關數據
AVITA Medical Inc簡介
AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.
公司代碼RCEL
公司AVITA Medical Inc
CEOVance (Cary G)
網址https://www.avitamedical.com/
公司股東
常見問題
AVITA Medical Inc(RCEL)的當前股價是多少?
AVITA Medical Inc(RCEL)的當前股價是 4.63。
AVITA Medical Inc 的股票代碼是什麼?
AVITA Medical Inc的股票代碼是RCEL。
AVITA Medical Inc股票的52週最高點是多少?
AVITA Medical Inc股票的52週最高點是7.12。
AVITA Medical Inc股票的52週最低點是多少?
AVITA Medical Inc股票的52週最低點是3.22。
AVITA Medical Inc的市值是多少?
AVITA Medical Inc的市值是712.48M。
現在AVITA Medical Inc(RCEL)的股票是買入、持有還是賣出?
根據分析師評級,AVITA Medical Inc(RCEL)的總體評級為買入,目標價格為7.00。
AVITA Medical Inc(RCEL)股票的每股收益(EPS TTM)是多少
AVITA Medical Inc(RCEL)股票的每股收益(EPS TTM)是-1.74。